Telehealth in Florida

Florida's telehealth framework pairs easy access for most routine care with a few high-impact guardrails patients should understand up front.

Care is legally delivered where you are, so a clinician who treats you while you are in Florida must be authorized here or registered through the state's out-of-state telehealth program.

Private plans generally cover clinically appropriate telehealth, but payment amounts are set by contract. Patients in Florida commonly use virtual care for GLP-1-based weight management, men's hormone services, dermatology, and longevity-style wellness.

The single rule that drives decisions is the standard of care: a remote visit must be as safe and complete as an office visit. One critical Florida-specific point is that controlled substances may not be prescribed by telehealth except in limited settings defined by state law.

Telehealth legality in Florida

Florida regulates telehealth as a mode of practice rather than a different specialty. The standard of care applies to every encounter. If a physical exam is necessary to make a safe decision, your clinician should arrange in-person care or refer you locally.

Authorization follows the patient's location. A clinician who treats a patient physically in Florida needs Florida authority to practice. Florida also offers an out-of-state telehealth registration for eligible clinicians who hold an active, unencumbered license elsewhere and meet Florida's disclosure and record-keeping requirements. Programs verify each clinician's status before scheduling visits.

Modality is flexible. Real-time audio-video is the workhorse for establishing care and changing therapy. Asynchronous store-and-forward (for example, a dermatologist reviewing high-quality photos with a documented plan) is used when it meets the standard of care. Remote patient monitoring supports selected chronic conditions. Phone-only visits are used more narrowly; whether they are covered depends on payer policy. Email or text by themselves are not considered telehealth encounters. Florida does not require a telepresenter to sit with the patient, and your home can serve as the site of care for most programs.

Prescribing and safeguards

GLP-1 and dual-agonist medicines for chronic weight management may be prescribed by telehealth when labeled indications are met, typically obesity or overweight with a related condition. Expect a structured intake that covers medical history, current medicines and allergies, and risk factors such as pancreatitis, gallbladder disease, and a personal or family history of medullary thyroid carcinoma. Many programs obtain baseline labs like A1c or fasting glucose and kidney function based on clinical risk, with pregnancy testing when appropriate. Doses start low and increase gradually. Side effects such as nausea are monitored during the first weeks. Follow ups are usually monthly during titration, then every 8-12 weeks once stable. Good programs pair medication with nutrition, activity, and sleep coaching. Brand names you may encounter include semaglutide and tirzepatide products (Ozempic, Wegovy, Zepbound).

Controlled substances have Florida-specific limits. Under state law, clinicians may not use telehealth to prescribe controlled substances except in narrow circumstances such as inpatient hospital care, hospice, certain nursing-home settings, or treatment of a psychiatric disorder. For most outpatient scenarios that means Schedule II and III medicines are not prescribed during a telehealth visit. In practice this affects men's testosterone therapy: testosterone is Schedule III, so clinics typically require at least one in-person visit to initiate and handle prescriptions, then use telehealth for follow-ups and lab review. Florida prescribers and pharmacists also consult the state prescription monitoring program before initiating or continuing many controlled medicines, and electronic prescribing is the default with limited exceptions.

Compounding and pharmacy shipping rules matter for remote care. Any pharmacy that ships prescriptions to a Florida address must hold the correct nonresident permit with the Florida Board of Pharmacy. Compounded versions of GLP-1 drugs became more common during national shortages. As commercial supply has stabilized, copying approved products with compounded versions is reserved for narrow, patient-specific needs such as a required formulation that is not commercially available. Patients should confirm that any dispensing pharmacy is authorized to ship to Florida.

Patient eligibility and intake

Telehealth follows the patient. If you are in Florida during your visit, the clinician must be authorized to practice here or registered under Florida's out-of-state program. Clinics verify identity and location at the start of each encounter, often by checking a government photo ID and confirming your current city. Informed consent is required. In practice, consent means your clinician explains what telehealth involves, potential risks and benefits, alternatives, and privacy protections, and you agree to proceed. Programs also provide standard privacy notices and maintain records to the same standard as in-person care.

For minors, a parent or legal guardian usually consents and participates in decisions in a developmentally appropriate way. Florida allows minors to consent to certain services in defined circumstances; when capacity or guardianship is uncertain, clinicians follow the same steps they would use for office care and document who is authorized to consent.

Florida Medicaid encounters follow program guidance. The home is an allowed originating site. The medical record should show that consent was obtained, where the patient was located, which modality was used, and that the visit met the standard of care. Managed care plans may require prior authorization for selected services and medications; clinics confirm plan-specific steps during intake.

Insurance and reimbursement

Commercial coverage for telehealth in Florida is strong. Plans generally cover clinically appropriate virtual visits to the same extent as in-person care when the underlying service is covered and the clinician is in network. Payment amounts are negotiated by contract; Florida law does not mandate across-the-board payment parity. Carriers can set reasonable technology standards and decide how audio-only visits are handled. Patient cost sharing for a covered telehealth service is typically aligned with the same service in person.

Florida Medicaid covers a broad set of telemedicine and telehealth services when medically necessary, including live video, audio-only for certain services, and remote patient monitoring for eligible conditions. The patient's home and other community settings are valid locations. Claims use the correct modifiers and place-of-service codes. Prior authorization rules for the underlying service or medication still apply.

Condition-specific telehealth availability

GLP-1 & weight loss

Availability: Statewide through health systems and national platforms employing Florida-authorized or Florida-registered prescribers.

Clinical expectations: Confirm indication and screen for contraindications. Gather baseline metrics and order targeted labs. Start at a low dose and step up monthly, with GI-side-effect counseling. Reassess weight trend, tolerability, and adherence every 8-12 weeks once stable.

Regulatory notes: If a compounded alternative is proposed, ensure a documented patient-specific need and use a pharmacy permitted to ship into Florida.

Common provider models: Obesity-medicine programs, virtual-first clinics, and integrated health systems offering semaglutide, tirzepatide, Wegovy, and Zepbound.

Skin care (tretinoin, hydroquinone protocols, spironolactone)

Availability: Teledermatology and primary-care teleclinics manage acne, hyperpigmentation, and maintenance therapy.

Clinical expectations: For acne, programs combine photo review with focused video, escalate topical retinoids and adjuncts, and consider oral spironolactone for eligible adults after blood-pressure and medication review. Hydroquinone protocols require counseling on limits to duration, application technique, and sun protection. Follow up every 6-12 weeks during active treatment is common.

Regulatory notes: Some depigmenting combinations are compounded; pharmacies shipping into Florida must hold the appropriate nonresident permit. If isotretinoin is used, expect monthly follow-ups within the national safety program.

Longevity & wellness injections (NAD+, Lipo-B/MIC+B12, Lipo-C, compounded glutathione)

Availability: Concierge wellness clinics and telehealth programs that coordinate local injection or infusion sites.

Clinical expectations: These products are not FDA-approved to treat aging. Responsible programs screen for cardiovascular risk and medication interactions, explain uncertain benefit and potential harms, and emphasize evidence-based prevention. IV therapies require in-person administration; telehealth supports evaluation, consent, and lab review.

Regulatory notes: Compounded products must come from licensed pharmacies that meet federal and state standards; shipping into Florida requires the correct permit.

TRT & men's health (testosterone cypionate or gel, enclomiphene, hCG)

Availability: Men's-health teleclinics and health-system endocrinology/urology services staffed by Florida-authorized or registered prescribers.

Clinical expectations: Confirm symptomatic hypogonadism with two separate low morning testosterone levels. Baseline hematocrit and, when appropriate for age and risk, PSA. Recheck testosterone and hematocrit about three months after initiation and periodically thereafter; adjust dose or route for efficacy and safety.

Regulatory notes: Because Florida prohibits prescribing controlled substances via telehealth in most outpatient settings, testosterone (Schedule III) typically requires an in-person visit for initiation and prescriptions. Telehealth is then used for monitoring, counseling, and lab review. Enclomiphene and hCG are not controlled substances and may be considered, when appropriate, under standard telehealth rules with informed consent.

State resources and next steps

Helpful contacts include the Florida Board of Medicine and Board of Osteopathic Medicine for physician practice questions, the Florida Department of Health's telehealth provider registration program for out-of-state clinicians, the Florida Board of Pharmacy for pharmacy and nonresident permits, the state prescription monitoring program (E-FORCSE) for controlled-substance queries, the Agency for Health Care Administration for Medicaid coverage and billing, and the Office of Insurance Regulation for commercial plan questions.

Practical next steps: confirm your clinician's Florida license or telehealth registration, ask exactly how they handle labs and follow-up during GLP-1 titration, and verify whether any hormone prescriptions require an in-person visit under Florida's controlled-substance rules. Check that the dispensing pharmacy is permitted to ship to your address and clarify your plan's telehealth benefits before your first visit.